Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy

Urology Journal

Volumn 6, Issue 1, 2009, Pages 9-13

  Djaladat, Hooman ^a   Mahouri, Khatereh ^a   Shooshtary, Fatemeh Khalifeh ^a   Ahmadieh, Azadeh ^b  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lithotripsy; Prospective studies; Terpenes; Therapy; Urinary calculi

Indexed keywords

ROWATINEX; TERPENE;

ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; FEMALE; HUMAN; IRAN; LITHOTRIPSY; MALE; MIDDLE AGED; NEPHROLITHIASIS; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IRAN; KIDNEY CALCULI; LITHOTRIPSY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; SINGLE-BLIND METHOD; TERPENES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 64549088986     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Stoller ML, Bolton DM. Urinary stone disease. In: Tanagho EA, McAninch JW, editors. Smith's general urology. 15th ed. New York (USA): Lange Medical Books/McGraw-Hill; 2000. p. 291-320.
2. Pearl SM, Lotan Y. Urinary lithiasis: etiology, epidemiology and pathogenesis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 1363-73.
3. Lingeman JE, Matlaga BR, Evan AP. Surgical management of upper urinary tract calculi. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007. p. 1431-58.
4. Tan YH, Wong M. How significant are clinically insignificant residual fragments following lithotripsy? Curr Opin Urol. 2005;15:127-31.
5. Siller G, Kottászs S, Pálfi Z. Rowatinex kapszula hatékonyságának vizsgálata ESWL-kezelés után keletkezett kõfragmentumokra. Magyar Urologia. 1998;10:139-46.
6. Engelstein D, Kahan E, Servadio C. Rowatinex for the treatment of ureterolithiasis. J Urol (Paris). 1992;98:98-100.
7. Fine JK, Pak CY, Preminger GM. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol. 1995;153:27-32.
8. Cicerello E, Merlo F, Gambaro G, et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol. 1994;151:5-9.
9. Mukamel E, Engelstein D, Simon D, Servadio C. The value of Rowatinex in the treatment of ureterolithiasis. J Urol (Paris). 1987;93:31-3.
10. Al-Mosawi AJ. A possible role of essential oil terpenes in the management of childhood urolithiasis. Therapy. 2005;2:237-47.
11. Miller R. [Experiences in the treatment of urolithiasis with Rowatinex]. Fortschr Med. 1967;85:39-42. German.
12. Losek RL, Mauro LS. Efficacy of tamsulosin with extracorporeal shock wave lithotripsy for passage of renal and ureteral calculi. Ann Pharmacother. 2008;42:692-7.
13. Arrabal-Martin M, Fernandez-Rodriguez A, Arrabal-Polo MA, Garcia-Ruiz MJ, Zuluaga-Gomez A. Extracorporeal renal lithotripsy: evolution of residual lithiasis treated with thiazides. Urology. 2006;68:956-9.